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Tuning a polar molecule for selective cytoplasmic delivery by a
pH (Low) Insertion Peptide
Dayanjali Wijesinghe1, Donald M. Engelman2, Oleg A. Andreev1, and Yana K. Reshetnyak1
1Physics Department, University of Rhode Island, 2 Lippitt Rd., Kingston, RI, 02881, USA
2Department

of Molecular Biophysics and Biochemistry, Yale University, P.O. Box 208114, New
Haven, CT 06520, USA

Abstract
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Drug molecules are typically hydrophobic and small in order to traverse membranes to reach
cytoplasmic targets, but we have discovered that more polar molecules can be delivered across
using water-soluble, moderately hydrophobic membrane peptides of the pHLIP® (pH Low
Insertion Peptide) family. Delivery of polar cargo molecules could expand the chemical landscape
for pharmacological agents that have useful activity but are too polar by normal drug criteria. The
spontaneous insertion and folding of the pHLIP peptide across a lipid bilayer seeks a free energy
minimum, and insertion is accompanied by a release of energy that can be used to translocate cellimpermeable cargo molecules. In this study we report our first attempt to tune the hydrophobicity
of a polar cargo, phallacidin, in a systematic manner. We present the design, synthesis and
characterization of three phallacidin cargoes, where the hydrophobicity of the cargo was tuned by
the attachment of diamines of various lengths of hydrophobic chains. The phallacidin cargoes
were conjugated to pHLIP, and shown to selectively inhibit the proliferation of cancer cells in a
concentration-dependent manner at low pH.

Keywords
pHLIP; phallacidin; hydrophobicity; translocation across membrane; drug design; drug delivery;
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Introduction
Targeted drug delivery would allow drugs to preferentially affect diseased cells, enhancing
therapeutic efficacy while reducing side effects. Targeting could be particularly important
for cancer therapy, since most anti-cancer drugs are toxic, not only killing cancer cells but
also causing serious damage to healthy tissues. Despite significant progress toward drugs
that specifically target protein biomarkers for certain kinds of cancer cells, there is still no
“silver bullet” against cancer. One reason for the limited success so far is that cells in tumors
are heterogeneous and selection for resistance to protein-targeted drugs and to the immune
system can occur (1). An alternative might be to find a targeting mechanism that does not
depend on a selectable marker. One of the universal differences between cancerous and
normal tissues is that the former exhibit a significantly acidic extracellular environment.
Acidosis is a hallmark of solid tumor development at both very early and advanced stages,
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as a consequence of anaerobic metabolism (the Pasteur effect) (2) and “aerobic glycolysis”
known as the Warburg effect (3).
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To target acidic tissues, we have developed a new approach, based on the action of a watersoluble, moderately hydrophobic membrane polypeptide, pHLIP (pH Low Insertion
Peptide), derived from the bacteriorhodopsin C helix. pHLIP is a soluble peptide that was
found to fold and insert across a membrane to form a stable transmembrane alpha helix
under acidic conditions (4). When triggered by low pH, members of the pHLIP peptide
family act as monomeric, membrane-inserting peptides that translocate their carboxyl
termini across membranes into the cytoplasms of targeted cells, while the amino termini
remain in the extracellular space, locating the peptide across the plasma membrane lipid
bilayers (5). Because the insertion occurs at low pH, acidic tissues are targeted, and so
pHLIP has a dual delivery capability: it can tether N-terminus linked cargo molecules to the
surfaces of cells in diseased tissues and it can move a C-terminus linked, cell-impermeable
cargo molecule across the membrane into the cytoplasm using the free energy of insertion
and folding (6, 7). Use of a cleavable link, such as a disulfide, releases the cargo inside the
cell (8, 9). Low pH leads to the protonation of negatively charged residues (Asp or Glu),
which enhances peptide hydrophobicity, increasing the affinity of the peptide for the lipid
bilayer and triggering peptide folding and subsequent membrane insertion (10-12). The
source of energy for moving polar molecules attached to pHLIP through the hydrophobic
layer of a membrane is the membrane-associated folding of the polypeptide (13-15). The
affinity of peptide for a membrane at low pH is about 5 times higher than at high pH,
allowing pHLIP to distinguish and mark acidic diseased tissue (10, 16, 17) associated with
various pathological states, such as cancerous tumors, inflammation, ischemia, stroke and
others.
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Our recent findings indicate that pHLIP facilitates the translocation of phalloidin, a cellimpermeable polar toxin, which leads to the inhibition of the proliferation of cancer cells in
a pH-dependent fashion (8). However, the antiproliferative effect was observed only when a
hydrophobic facilitator (rhodamine) was attached to the peptide inserting end. An alternative
approach is to modify the properties of the cargo molecule to optimize delivery, and the goal
of this study is to tune properties of the pHLIP-cargo constructs to achieve the most efficient
pH-dependent translocation of cargo molecules across the lipid bilayer. The properties of a
molecule delivered into cells will help to define the chemical landscape available for the use
of pHLIP. Here we present the design, synthesis and characterization of three phallacidin
cargoes, where the hydrophobicity of the cargo was tuned by attachment of diamines having
various lengths of hydrophobic chains. Three constructs, where pHLIP was linked to
phallcidin cargoes of different polarity were synthesized, characterized, and tested the
antiproliferative effect on cultured cells.

Materials and Methods
Peptide preparation
The pHLIP peptide (AEQNPIYWARYADWLFTTPLLLLDLALLVDADEGCT) was
prepared by solid-phase peptide synthesis at the W.M. Keck Foundation Biotechnology
Resource Laboratory at Yale University. The lyophilized powder was soluble in 3 M urea or
DMSO (dimethyl sulfoxide). When dissolved in urea the peptide was transferred to buffer
using a G-10 size-exclusion spin column. The concentration of the peptide was determined
spectrophotometricly by measuring absorbance at 280 nm (ε280=13,940 M-1cm-1).
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Synthesis of phallacidin-(CH2)n-SH
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Materials—Phallacidin was purchased from GenoLite Biotek, N-hydroxysuccinimide
(NHS), N, N'-dicyclohexylcarbodiimide (DCC), N-succinimidyl 3-(2-pyridyl-dithio)propionate (SPDP) were from Thermo Scientific, Hexamethylenediamine 98%, 1,4diaminobutane 99%, 1,10-diaminodecane 97% were from Sigma Aldrich.
Step1—Phallacidin (2.6 mg, 3.10 µmol) was dissolved in 100 µl dry DMF
(dimethylformamide) and transferred into a 1.5 ml glass vial followed by addition of NHS
(2.5 mg, 21.6 µmol, 7 eq) in 30 µl dry DMF and mixed well. DCC (1.15 mg, 5.57 µmol, 1.8
eq) was added to the reaction mixture. The reaction mixture was stirred at room temperature
overnight, then the reaction mixture was centrifuged and separated from the urea crystals.
The progress of the reaction was monitored by reverse phase HPLC (high-performance
liquid chromatography) at t=0 and at t=12 hrs. (Agilent Technologies Zorbax SB-C184.6 ×
250 mm column; flow rate 1 ml/min; phase A water + 0.05% TFA (trifluoroacetic acid);
phase B acetonitrile + 0.05% TFA; gradient 30 min from 95:5 A/B to 50:50 A/B) The
phallacidin starting material elutes at 24.9 min, while activated
hydroxysuccinimidephallacidin elutes at 23.6 min. The reaction was completed by 12 hrs.
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Step2—The supernatant from the step 1, which contained the activated
hydroxysuccinimidephallacidin was added into diamines H2N-(CH2)n-NH2 (n=4, 6 or 10)
dissolved in dry DMF (31 µmol, 10 eq of phallacidin) and the reaction mixture was stirred at
room temperature for 10 hrs. The addition of the diamine resulted in the formation of a
precipitate: dehydrated phallacidin diamine salt. The product, phallacidin-(CH2)nNH2
(phallCn) was found both in the precipitate and in the supernatant. The precipitate was
separated by centrifugation and dissolved in 120 µl MeOH/H2O (1:1). The product was
purified using HPLC and lyophilized. The elution times of phallacidin-(CH2)4NH2
(phallC4), phallacidin-(CH2)6NH2 (phallC6) and phallacidin-(CH2)10NH2 (phallC10) were
23.1, 24.6 and 29.5 min, respectively as expected from the increasing hydrophobicities. The
lyophilized powder was then dissolved in 100 µl of MeOH/H2O (1:1), quantified by
measuring OD (optical density) at 300 nm (ε300 of phallacidin: 10,100 M-1cm-1) and
analyzed using ESI (electronspray ionization) mass spectrometry. Molecular weights (MW)
of the phallotoxins phallC4, phallC6 and phallC10 were 917.23, 945.18 and 1001.22 Da,
respectively (the expected MWs are 917.06, 945.12 and 1001.23 Da).
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Step 3—The products from step 2 (in 100 µl of MeOH/Water 1:1) were transferred into
200 µl of 100 mM phosphate buffer at pH 8. A solution of SPDP (starting from 5 eq of
phallCn) in DMSO was added to the reaction mixture and stirred at room temperature. After
about 2 hrs, most of the SPDP was hydrolyzed to PDP and no further progression of
formation of the phallCn-PDP was observed. The pH of the reaction mixture was adjusted to
pH 8 and more SPDP was added until almost all phallCn was reacted. The progress of the
reaction was monitored using HPLC. Phallacidin-(CH2)n-SH (phallCnSH) was obtained by
reducing the disulfide bond in the phallCn-PDP using TCEP (20 eq to SPDP added) in 100
mM phosphate buffer pH 8 for 30 min, purified using reverse phase C18 HPLC, lyophilized,
and characterized using ESI mass spectrometry. The elution times and MWs of phallotoxins
on HPLC runs with 30 min gradients from 99:1 A/B to 70:30 A/B (flow rate 1 ml/min)
were: for phallacidin 30.3 min/ 846.15 Da, for phallC4SH 32.4 min/1005.17 Da, for
phallC6SH 35.5 min/1033.03 Da and for phallC10SH 44.4 min/1089.07 Da.
Synthesis of pHLIP-S-S-(CH2)n-phallacidin
The lyophilized phallCn-PDPs were dissolved in DMSO to have about 5 mM, followed by
the addition of pHLIP peptide (2 eq) dissolved in DMSO and incubated at room
temperature. More pHLIP was added if needed until almost all phallCn-PDPs were reacted.
Biochemistry. Author manuscript; available in PMC 2012 November 29.
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The progress of the reaction was monitored using HPLC (flow rate 1 ml/min; gradient 60
min from 99:1 A/B to 5:95 A/B). The pHLIP-Cnphall were analyzed using SELDI-TOF
(surface-enhanced laser desorption/ionization time-of-flight) mass spectrometry and
quantified by measuring OD at 280 and 300 nm. (ε280 / ε300 of pHLIP and phallacidin is
13940 M-1cm-1/2999 M-1cm-1 and 10944 M-1cm-1/10100 M-1cm-1, respectively)
Measurements of water-octanol partition coefficient
The polarities of the phallotoxin cargoes were determined by assessment of relative
partitioning between aqueous and octanol liquid phases. Constructs dissolved in
MeOH:Water 1:1 were added to 0.5 ml of 10 mM phosphate buffer pH 5.5 (saturated with
argon) to concentrations of 20 and 30 µM, followed by the addition of argon saturated noctanol (0.5 ml) and sealed under argon. The solutions were mixed by rotation for 24 hrs at
room temperature and left for another 24-48 hrs to reach equilibrium. After phase
separation, absorption at 300 nm was recorded. The molar extinction coefficients in noctanol and phosphate buffer are assumed to be the same, and the ratio of the OD readings
was used directly to calculate the partition coefficient, P = ODn-octanol /ODwater, and Log P
values. A fraction of aqueous solution was analyzed using HPLC to ensure that no dimers of
the phallotoxin were formed.
Liposome preparations
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Liposomes were prepared by extrusion: POPC (1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine) (500 µl of 10 mg/ml in chloroform) was transferred to a 100 ml round
bottom flask and a lipid layer was obtained by evaporating the choloroform in a rotary
evaporator, followed by drying under high vacuum for 2 hrs. The lipid layer was
resuspended in 10 mM phosphate buffer, pH8, and extruded 31 times through a 50 nm
membrane to obtain large unilamellar vesicles.
Measurements of intrinsic peptide fluorescence and circular dichroism (CD) spectroscopic
signals
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Intrinsic peptide fluorescence and circular dichroism (CD) spectra were measured on a PC1
ISS spectrofluorometer (ISS, Inc.) and a MOS-450 spectrometer (Bioligic, Inc.),
respectively, under temperature control. All measurements were performed at 25°C.
Samples of 7µM of pHLIP-Cnphall incubated with 1.5 mM POPC or in buffer pH8
overnight were used for the measurements of CD and fluorescence signals of the three
states. 4 µM of the pHLIP-Cnphall in pH8 incubated overnight were used for the experiment
for aggregation of the peptide-cargo in aqueous medium. Peptide fluorescence spectra were
recorded from 310 nm to 400 nm using excitation wavelengths of 280 nm. Peptide CD
spectra were recorded from 190 nm to 260 nm at 0.5 nm increments using a sample cuvette
with an optical path length of 0.5 cm.
Binding assay
Materials and preparation of stock solutions—Rabbit muscle actin was purchased
from Cytoskeleton Inc. To obtain polymerized filamentous actin (F-actin), the monomeric
globular actin (G-actin) was dissolved in 100 µl of water and incubated for 1 hr at room
temperature. After centrifuging at 13,000×g for about 15 min, the amount of G-actin in the
supernatant was quantified by measuring the OD at 290 nm (ε290 of G-actin is 26 600
M-1cm-1). G-actin was diluted to 3.5 mg/ml in 2 mM phosphate buffer pH 8 supplemented
with 0.2 mM CaCl2 and 0.2 mM ATP and incubated for 1 hr at 4°C. Polymerization was
induced by addition of 50 mM KCl, 2 mM MgCl2 and 1 mM ATP and incubation for 1 hr at
room temperature. Texas Red-X phalloidin (PhallTxR) was purchased from Invitrogen
Corp. PhallTxR was dissolved in DMF and quantified by measuring OD at 583 nm. (ε583 of
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PhallTx in MeOH is 95,000 M-1cm-1). Previously prepared and lyophilized phallotoxins
(phallacidin, phallC4SH, phallC6SH and phallC10SH) were dissolved in DMSO and
quantified by measuring OD at 300 nm. (ε300 of phallotoxins 10,100 M-1cm-1).
Binding assay of phallTxR to actin—Samples of 0.6 µM of phallTxR with different Factin concentrations (from 0 to 6.6 µM) were prepared in polymerizing buffer (2 mM
phosphate buffer pH8 containing 50 mM KCl, 2 mM MgCl2, 0.2 mM CaCl2 and 1 mM
ATP) and incubated for 2 hrs at room temperature. The fluorescence anisotropy and
intensity of each sample were measured with excitation/emission setting at 570 nm/ 610 nm
wavelength, respectively under temperature control.
Competition binding assay—The assay is based on titration of 0.3 µM of phallTxR and
0.3 µM of phallotoxin by increasing concentrations of F-actin. 10× TCEP was added to 60
µM stock solution of phallotoxins in polymerizing buffer and incubated for 10 min to reduce
disulfide bond. Samples of 0.3 µM of phallTxR and 0.3 µM of each phallotoxin were
prepared in polymerizing buffer followed by mixing with F-actin to obtain final
concentrations of 0, 0.3, 0.6, 1.2 and 2.4 µM of F-actin in each sample, and incubated
overnight at 4°C. The fluorescence anisotropy of each sample was measured with excitation/
emission setting to 570 nm/ 610 nm measured using PC1 spectrofluorometer under
temperature control.
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Cell line
Human cervical adenocarcinoma HeLa was purchased from the American Tissue and
Culture Collection (ATCC). HeLa was propagated in DMEM (Dulbecco's Modified Eagle
Medium) ([+] 4.5 g/L D-glucose, [+] 40 mg/L sodium pyruvate, Gibco) supplemented with
10% FBS (fetal bovine serum) (Gibco), ciprofloxacin-HCl (1 µg/mL) (from Cellgro, Voigt
Global Distribution) in a humidified atmosphere of 5% CO2 at 37°C. HeLa cells were
adapted to pH 6.2 by propagation in pH 6.2 DMEM supplemented with 10% FBS,
ciprofloxacin-HCl (1 µg/mL) in humidified atmosphere of 5% CO2 at 37°C.
Proliferation Assay
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Stock solutions of phallacidin, phalloidin-oleate, phallCnSH and pHLIP-Cnphall were
prepared in DMSO at 400 µM. A human cervix adenocarcinoma cell line (HeLa) obtained
from the ATCC (American Type Culture Collection) was grown at pH 6.2 and 7.4. HeLa
cells were seeded in 96-well plates (Costar) at densities of 4000 and 2000 cells per well for
treatment on the following day. A DMSO stock of constructs were diluted with sterile
Leibovitz's L-15 phenol free medium (L-15) pH 6.0 or 7.4 to give treatment solutions in the
0-6 µM range. Appropriate amounts of DMSO were added to ensure that all treatment
samples contain the same amount of DMSO by volume (1.5%). After removal of cell media,
the L-15 treatment solutions pH 6.0 or 7.4 (95 µL) were added to cells grown at pH 6.2 and
7.4, respectively, and then the plate was incubated at 37°C for 3 hrs. After treatment, 200 µL
of DMEM at pH 6.2 or 7.4 were added to corresponding wells and 10 µl of FBS into each
well to provide 10% of FBS in cell medium before returning the plate to the incubator. Cell
density of the ‘0 µM, pH 6.2’ and ‘0 µM, pH 7.4’ controls usually reached 80%-90%
saturation in well after 4-6 days of growth. The viable cell number was quantified using the
MTS reagent (Promega CellTiter 96 AQueous One Solution Cell Proliferation Assay). OD
values at 490 nm were obtained using a plate reader (iMark Microplate reader from Bio
Rad). Since the rate of cells growth is slightly different at low and neutral pHs, all numbers
were normalized to 100% using wells where no construct was added to the media at various
pHs.
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Results
Design and synthesis of phallacidin cargoes of different hydrophobicity

NIH-PA Author Manuscript
NIH-PA Author Manuscript

The major goal of our work is to systematically vary the hydrophobicity of a polar cargo,
phallatoxin, and to investigate pHLIP-mediated pH-dependent cellular delivery of constructs
of different polarity of cargoes. We chose phallacidin (Figure 1), which is a cyclic cellimpermeable toxin similar to phalloidin and that binds to F-actin with high affinity (18, 19).
Phallacidin has a free COOH group suitable for conjugation purposes, and we tuned the
hydrophobicity of the phallacidin cargo by reacting with diamines NH2-(CH2)n-NH2 with
different lengths of hydrophobic chain (CH2)n, where n could vary from 2 to 12 carbon
atoms. We had already tested commercially available phalloidin-oleate, with 15 carbon
atoms, which has Log P value of +1.7, and observed inhibition of Hela cell proliferation rate
by 60%, 70% and 95% after treatment cells with 1, 2 and 4 µM of phalloidin-oleate,
respectively (data not shown), which indicate that attachment of 15 carbon atoms to
phalloidin makes it too hydrophobic, so it can easily cross lipid bilayer itself. We selected 3
different lengths of hydrophobic chain diamines, where n is 4, 6 and 10 to work with. The
phallacidin was conjugated to the various lengths diamines via NHS and DCC crosslinker.
We synthesized three phallacidin cargoes with four (phallC4), six (phallC6) and ten
(phallC10) carbon atoms. The protocol was adjusted until optimal conditions were
established, and the details of the final protocol are in the Methods section. The products
were purified using reverse phase C18 HPLC, lyophilized and characterized by ESI mass
spectrometry. The molecular weights obtained for phallacidin cargoes were 917.2 Da for
phallC4, 945.2 Da for phallC6 and 1001.2 Da for phallC10 and were very close to expected
values (917.1, 945.1 and 1001.2 Da).
Characterization of phallacidin cargoes of different hydrophobicity
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To investigate the properties of cargo molecules, they were reacted with SPDP crosslinker,
the S-S bond was reduced by TCEP and the reduced cargoes were purified and characterized
(see Table 1). The cargo hydrophobicities were evaluated by measuring the logarithm of the
octanol-water partition coefficient P, calculated based on the amount of constructs
distributed upon equilibration between octanol and water phases, measured by the ODs of
phallacidin constructs at 300 nm. The Log P values of phallacidin and cargoes are presented
in Table 1. Phallacidin with a long chain FA of ten carbon atoms is preferably distributed
into octanol, being hydrophobic, and shows a positive Log P of +1.28. Such molecules are
expected to cross cellular membranes by themselves (at least at high concentrations), the
hydrophobicity being in the range of conventional drugs. The polarity of phallC6SH with
Log P = -0.09 was very close to the polarity of phalloidin-rhodamine, which has Log P =
-0.05 measured previously (20). Phallacidin with four carbon atoms, as expected, was the
most polar among modified phallacidin cargoes.
According to the literature (18, 21, 22) it was expected that modification of COOH group of
phallacidin should not affect F-actin binding properties. Phallatoxin binds between actin
monomers in filamentous actin and prevents depolymerization (19, 21). We used a
fluorescence anisotropy titration assay, where phalloidin conjugated to Texas Red (TxR)
fluorescent dye was in competition with phallacidin and cargoes for F-actin binding. The
assay is based on the increase of anisotropy of phallTxR when it binds to the F-actin.
Samples of equal concentration (0.3 µM) of phallTxR and phallacidin cargoes were
prepared with increasing concentrations of F-actin. The samples were incubated overnight,
then the fluorescence anisotropy of each sample was measured at 610 nm wavelength with
excitation at 570 nm (Figure 2). The anisotropy changes from 0.04 (for unbound phallTxR)
up to 0.24 when all phallTxR is completely bound (the value of 0.24 was obtained in
separate titration experiment of phalloidinTxR by F-actin in the absence of phallacidin or
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phallacidin cargoes). Our experiments demonstrate that the anisotropy value in the presence
of phallacidin cargoes changes in the same way as anisotropy in the presence of phallacidin,
confirming that the attachment of hydrophobic tails to the phallacidin does not alter binding
affinity to F-actin.
Synthesis and characterization of pHLIP-Cn phall
We synthesized pHLIP-C4phall, pHLIP-C6phall and pHLIP-C10phall constructs, purified
them, performed spectroscopic characterization and tested their anitproliferative properties.
PhallCn-PDP were conjugated with single Cys residue at the C-terminus of pHLIP to form a
S-S bond. The products were purified using reverse phase C18 HPLC, lyophilized and
characterized by SELDI-TOF mass spectrometry (MW of the pHLIP-C4phall, pHLIPC6phall and pHLIP-C10phall were 5120.1, 5155.4 and 5204.2 Da respectively) and
quantified by measuring OD at 280 and 300 nm.
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We have demonstrated previously that changes of intrinsic fluorescence and CD of pHLIP in
the presence of liposomes resulting from pH changes is indicative of peptide insertion into
the lipid bilayer (4, 5). Here, we carried out spectroscopic characterization of pHLIP-Cnphall
constructs (Figure 3). We found that all constructs are predominantly unstructured in
aqueous solution at pH8, while the position of the maximum of fluorescence is slightly
shifted to short wavelengths when cargo with longer carbon chain was conjugated to pHLIP
(Table 2). The shift of the position of maximum is accompanied with the increase of
ellipticity at 222 nm. All spectroscopic data indicate that pHLIP-C10phall most probably is
more aggregated compared to pHLIP, pHLIP-C4phall and pHLIP-C6phall. More
pronounced differences between constructs were observed at pH 8 in the presence of POPC.
The highest amount of helical structure and the deepest partition of the emitting residues
into the core of bilayer were observed for the pHLIP-C10phall. The lowering of pH from 8
to 4 induced further increase of helical content and partition of the constructs into the
membrane accompanied with the increase of fluorescence and shift of the emission to the
short wavelengths. The pH-induced fluorescence and CD changes seen for different
constructs in the presence of lipid bilayer were very similar to those observed for pHLIP
alone. These changed were more significant for pHLIP-C10phall compared to pHLIPC4phall. Thus, we concluded that conjugation of phallCn cargoes, in general, does not affect
the pH-dependent ability of pHLIP to interact with the membrane lipid bilayer.
Antiproliferative effect of pHLIP-Cn phall
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Finally, we tested the anitproliferative capability of the pHLIP-Cnphall constructs. HeLa
cells were adapted for low pH growth (pH 6.2). Cells grown at low and normal (7.4) pHs
were treated with increasing concentrations of the pHLIP-Cnphall, phallCn and phallacidin
in L-15 phenol free medium at pH 6.0 and 7.4 for 3 hrs. After treatment DMEM
supplemented with 10% FBS at pH 6.2 or 7.4 was added to corresponding cells. When cell
density in the control wells (treated with medium) reached 80%-90% saturation (after 4-6
days of growth) the number of viable cells was quantified using the MTS reagent. Since the
rate of cells growth is slightly different at low and neutral pHs, all numbers were normalized
to be 100% where no construct was added to the media. Phallacidin and phallCn cargoes do
not demonstrate an antiproliferative effect at either pHs (data not shown). At the same time,
the data clearly demonstrate that pHLIP-C4phall and pHLIP-C6phall show concentration
dependent antiproliferative effect only at low pH of treatment, while at neutral pH no effect
was observed (Figure 4). At 2 µM of pHLIP-C4phall and pHLIP-C6phall about 30% and
70%, respectively, of cell death was observed at low pH. As we expected, the increase of
cargo hydrophobicity correlates with the enhancement of antiproliferative effect. However,
surprisingly, we did not observe expected biological effect, when cells were treated with
pHLIP-C10phall.
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Conformational states of pHLIP-C10phall in solution at different pHs
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Since we treated cells with constructs at pH5.9-6.0 for 3 hours, the constructs were dissolved
in media at low pH. Previously, we demonstrated that pHLIP has tendency for the
aggregation in solution, when pH is lowered from 8-7.4 to 4-3 (5). When various cargoes are
attached to the peptide the overall hydrophobicity is altered, and solubility could be changed
as well. The overall hydrophobicity of the pHLIP-C10phall is higher than the
hydrophobicity of the pHLIP-C4phall, therefore, the tendency for the aggregation is higher
for the pHLIP-C10phall. We compared fluorescence and CD signals of pHLIP-C10phall in
aqueous solution at pH 8, 7.4 and 5.9 (Figure 5). The decrease of pH in range of 8 to 6 leads
to the conformational changes accompanied by the shift of the position of maximum of
fluorescence from 349 to 346 nm, the increase of amount of helical structure and the
reduction of quantum yield of fluorescence. These spectral changes were not observed in
case of pHLIP-C4phall and pHLIP-C6phall in the range of pH8-6 (data not shown). We
concluded that pHLIP-C10phall in solution at pH6 is partially aggregated, which alters its
interaction with the lipid bilayer of cellular membrane and leads to the reduction of
anitproliferative effect.

Discussion
NIH-PA Author Manuscript
NIH-PA Author Manuscript

In conventional drug design and discovery the Lipinski rules of five, or subsequently
developed similar parameters, are widely used to guide drug designs. The rules postulate
that a successful drug should be hydrophobic and small in order to traverse membranes and
reach cytoplasmic targets (e.g. the logarithm of the octanol-water partition coefficient Log P
is -0.4 to +5.6 and the MW is 160 to 480 g.mol-1) (23). However, the majority of inhibitors
found for biological targets located inside a cell are molecules that cannot cross a membrane
(24-26). We have proposed a novel way to deliver polar molecules across membranes, based
on the insertion of a water-soluble, moderately hydrophobic membrane peptide, pHLIP. The
spontaneous insertion and folding of the peptide into a lipid bilayer seeks the free energy
minimum, and the insertion event is therefore accompanied by a release of energy, which is
used to translocate cell-impermeable cargo molecules across a cellular membrane. The
Gibbs Free Energy of binding of pHLIP to a POPC surface at 37°C is about -7 kcal/mol at
pH8 and the additional free energy of insertion and folding across a lipid bilayer induced by
reduction of pH from 8 to 4 is nearly -2 kcal/mol (13). The energy difference between
membrane-bound and membrane–inserted states favors the partition of cargo across the
hydrophobic barrier of a membrane. Since the energy released during peptide folding and
insertion across a membrane is limited, and since strongly polar molecules will reach
equilibrium slowly, we assumed that there is a limit on cargo polarity (and most probably on
size as well) that can be delivered across a membrane by pHLIP. In support of that, we
recently show that pHLIP can move phalloidin across a membrane to inhibit cell
proliferation, but only when a hydrophobic facilitator (rhodamine) is attached to the peptide
inserting end. In this study we made a first attempt to tune hydrophobicity of polar cargo
phallacidin in a systematic manner by conjugation of phallacidin with diamines of different
hydrophobic chain lengths. The hydrophobicity of the cargo is modulated by presence of 4
to 10 carbon atoms conjugated to the carboxyl group of phallacidin. The cargoes were
synthesized and characterized. We show that the logarithm of the octanol-water partition
coefficient (Log P) of cargoes was varied from -1.6 for pure phallacidin to +1.28 for
phallC10. Cargo to be functional needs to bind to its cellular target, in the case of
phallacidin it is an F-actin. We evaluated the actin-binding ability of cargoes and
demonstrated that attachment of a chain of carbon atoms (up to 10 atoms) to the carboxyl
group of phallacidin does not affect their ability to interact with F-actin. Next, the phallCn
cargoes were conjugated via a cleavable S-S bond to the C-terminus of pHLIP, which goes
across the membrane. First, we carried out spectroscopic characterization of pHLIP-Cnphall
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cargoes. The experiments were done on model system of POPC liposomes. The constructs,
first, were dissolved in aqueous solution at pH8, then pre-incubated with liposomes at pH8,
and, after that, the pH was dropped from 8 to 4. The conditions of model experiment differ
from conditions of the experiments on cultured cells, while the conditions were chosen to
ensure completion of all transitions and for the comparison to our previously published
biophysical studies (4-13). In general, we observed characteristic changes of the
fluorescence and CD signals, when pHLIP-Cnphall interact with lipid bilayer of a POPC
membrane at neutral and low pHs as it was observed for pHLIP peptide (4-13). The changes
of spectroscopic signals were the most pronounced for the pHLIP-C10phall compared to the
pHLIP-C4phall. It was an important sign, indicating that attachment of phallCn cargo
molecules to the inserting end of the peptide does not prevent pH-dependent membrane
interaction of the peptide. Next, we carried out cell experiments to demonstrate that phallCn
could be translocated across a membrane by pHLIP to induce inhibition of cell proliferation.
It is known that phallacidin in the cytoplasm stabilizes actin in its filamentous form,
preventing depolymerisation. Since cell movement and shape changes are associated with
actin polymerization/depolymerisation, stabilization of F-actin depolymerisation leads to the
freezing of cell movement, formation of multinucleated cells and eventually cell death (8,
20). Phallacidin and phallCn did not show any biological effect at both pHs, while pHLIP
facilitated translocation of phallC4 and phallC6 cargoes at slightly acidic pH, which in turns
led to the inhibition of cell proliferation in a concentration-dependent manner. As we
expected, the antiproliferative effect was more significant in case of cell treatment with
pHLIP-C6phall compared to pHLIP-C4phall, since phallC6 is more hydrophobic than
phallC4. However, surprisingly we did not monitor the desired biological effect when cells
were treated with pHLIP-C10phall. Additional characterization of the conformation states of
pHLIP-C10phall in aqueous solutions in range of pH8-6 revealed that the construct has
much higher tendency for aggregation at pH6 (pH used to treat cells) in comparison to
pHLIP, pHLIP-C4phall and pHLIP-C6phall. As a result, the efficacy of treatment was
reduced. We concluded that increase of cargo hydrophobicity indeed facilitates its
translocation across membrane by pHLIP, however the requirement of construct solubility is
critical, since construct interaction will cellular membrane could be altered leading to the
reduced translocation ability and diminished biological effect.

NIH-PA Author Manuscript

In contrast to all other known peptide-based delivery technologies, selective delivery of
molecules into the cytoplasm by pHLIP is achieved by the pH-dependent folding of a
monomeric peptide across the plasma membrane. In response to the low extracellular pHs of
cells in diseased tissues, pHLIP can translocate polar therapeutic cargo molecules into cell
cytoplasms, whereas at the normal extracellular pH of healthy tissue, only a minimal
translocation of cargo across cell membranes would occur. Because the cargo is translocated
across a cell membrane directly into the cytoplasm, endosomal trapping is avoided. Tuning
the cargo hydrophobicity can be used to achieve the maximum difference between the
therapeutic effect at low pH versus at neutral pH, thereby enhancing diseased-targeted
delivery and reducing treatment side effects. However, to achieve the desired enhancement
of therapeutic efficacy, it is critical to ensure construct solubility, which could be reduced
due to the increase of cargo hydrophobicity.
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Figure 1.

Chemical structures of cyclic peptides: phalloidin, where R1 = OH and R2 = CH3;
phallodin-rhodamine where R1 = rhodamine; and phallacidin, where R1 = H and R2 =
COOH. Diamines consisting of different length of carbon chains (CH2)4, (CH2)6 and
(CH2)10 were attached to the COOH group (R2).
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Figure 2.

Binding competition assay. Changes of fluorescence anisotropy of Texas Red conjugated to
phalloidin (0.3 µM) was monitored in the presence of phallacidin or phallacidin cargoes (0.3
µM) at different F-actin concentrations.
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Figure 3.
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Changes of intrinsic fluorescence (a-c) and CD (d-f) spectral signals upon pHLIP-C4phall,
pHLIP-C6phall and pHLIP-C10phall interaction with POPC liposomes at various pHs.
Black lines represent spectra for the construct in aqueous solution at pH8, blue lines upon
incubation with POPC liposomes at pH8, and red lines after the pH was dropped from 8 to 4.
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Figure 4.

Inhibition of cell proliferation by pHLIP-C4phall, pHLIP-C6phall, pHLIP-C10phall at low
pH.
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Figure 5.

Intrinsic peptide fluorescence (a) and CD (b) spectral signals of pHLIP-C10phall at various
pHs.
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Table 1
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Characterization of phallacidin and phallalacidin-C4, -C6 and –C10 cargoes: percentage of acetonitrile of
cargo elutions from the column and the logarithms of the octanol-water partition coefficients (Log P).
Acetonitrile, %

Log P

phallacidin

20.3

-1.6

phallC4SH

22.4

-0.74

phallC6SH

25.5

-0.09

phallC10SH

34.4

+1.28
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Table 2
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The spectral parameters of the pHLIP-C4phall, pHLIP-C6phall and pHLIP-C10phall in the states I, II and III
are presented. The parameters were obtained in the result of the analysis of the fluorescence and CD spectra
shown on the Figure 3: the maximum position of the fluorescence spectrum λmax, S – the normalized area
under the spectra (normalization was done on the area under the spectrum in the state I); θ222 × 103, deg cm2
dmol-1 res-1 – the molar ellipticity at 222 nm.

pHLIP-C4phall

pHLIP-C6phall
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pHLIP-C10phall

State I

State II

State III

λmax

350.9 nm

346.6 nm

339.7 nm

S

1.0

1.08

1.05

θ222

-4.6

-4.1

-6.05

λmax

349.9 nm

348.3 nm

340.2 nm

S

1.0

1.03

1.31

θ222

-4.6

-5.2

-13.4

λmax

349.6 nm

344.6 nm

339.2 nm

S

1.0

1.28

1.82

θ222

-5.9

-7.0

-14.6
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